New York Cancer & Blood Specialists successfully challenged the New York State Department of Health’s restrictive definition of “oncologic protocol.”
UF Health officials and supporters gathered Wednesday to unveil the UF Health Cancer Center’s Mobile Cancer Screening Connector, which will take cancer screening care to a 23-county area in North Florida. UF Health photo by Nate GuidryThe University of Florida Health Cancer Center launched a 40-foot-long mobile cancer screening bus that will expand access to cancer screenings and essential health care services, including 3D mammograms and cervical, colon, and prostate cancer screenings.
The University of New Mexico Comprehensive Cancer Center has received reaccreditation from the Commission on Cancer, a quality program of the American College of Surgeons.
The National Coalition for Cancer Survivorship has released it’s 2024 State of Survivorship report findings.
Residents of U.S. neighborhoods with high concentrations of Latino residents often face significant socioeconomic challenges, including less access to health care, a study led by a UT Southwestern Medical Center researcher shows.
Scemblix (asciminib) was granted accelerated approval by FDA for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Pangea Biomed, a startup developing the Enlight cancer response prediction platform, announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University.
The National Cancer Institute approved the following clinical research studies last month.
NCI has launched a second-generation precision medicine clinical trial called Myeloid Malignancies Molecular Analysis for Therapy Choice, or myeloMATCH, a trial focused on acute myeloid leukemia and myelodysplastic syndromes.
The University of Hawai‘i Cancer Center has received a full five-year designation from NCI.
